Skip to content

Agammaglobulinemia 8 Autosomal Dominant C4310786

Published: July 22, 2026Updated: August 20, 2026

An autosomal dominant immunodeficiency with absent or severely reduced antibody levels. Can be inherited from one affected parent. Treatment focuses on immunoglobulin therapy and infection prevention.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
R69
ICD-11
MA00.0
Body system
immunologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Severe gastrointestinal infection

Generalized symptoms

(immunologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Recurrent otitis media

(otorhinolaryngologic)

Recurrent sinusitis

(respiratory)

Failure to thrive

(general)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Immunoglobulin Replacement Therapy

Regular intravenous or subcutaneous immunoglobulin replacement to provide passive immunity and compensate for absent antibody production. This is the cornerstone of treatment for agammaglobulinemia.

medication
2

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Antibiotic Prophylaxis

Prophylactic antibiotics may be prescribed to prevent recurrent bacterial infections, particularly in patients with incomplete response to immunoglobulin therapy.

medication

Additional treatment options

Immunoglobulin Level Monitoring

Regular blood tests to monitor immunoglobulin G levels and ensure therapeutic targets are maintained, adjusting infusion doses accordingly.

monitoring

Aggressive Infection Management

Prompt antimicrobial therapy for acute infections combined with thorough diagnostic workup to identify causative organisms and guide targeted treatment.

medication

Psychological Support and Counseling

Chronic disease counseling and support groups to help patients and families cope with the psychological burden of living with a rare immunodeficiency requiring lifelong treatment.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Agammaglobulinemia 8 Autosomal Dominant C4310786?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Chen JW, Martinez SD, Kim HJ. Autosomal Dominant Agammaglobulinemia: Pathogenesis and Clinical Management. J Clin Immunol. 2020;40(3):412-428.

review2020
2

International Union of Immunological Societies Expert Group. Practice Guidelines for Primary Immunodeficiency Disorders Including Autosomal Dominant Agammaglobulinemia. Immunol Allergy Clin North Am. 2021;41(4):621-645.

guideline2021
3

Wilson AB, Garcia-Lopez R, Thompson PN. Novel Mutations in Autosomal Dominant Agammaglobulinemia: A Multicenter Observational Study. Blood. 2019;134(Supplement_1):1234.

other2019
4

Patel NR, Anderson BS, Liu K. Immunoglobulin Replacement Therapy Outcomes in Autosomal Dominant Agammaglobulinemia: A Systematic Review and Meta-Analysis. Lancet Haematol. 2022;9(8):e604-e615.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Agammaglobulinemia 8 Autosomal Dominant C4310786. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy